Hyderabad-based pharma player Laurus Labs has received a licence from the DRDO for manufacturing and marketing the Covid-19 drug 2-Deoxy-D-Glucose in India.
The Russian Direct Investment Fund (RDIF) and Morepen Laboratories have announced the production of a test batch of Sputnik V in an exclusive facility in Himachal Pradesh.
EXAMIANS